Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhengguo Cao has a total of 229 co-authors. Here are the top co-authors by number of shared publications:

  • Li Ma

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine, Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, China

    23 shared publications
  • Xiaoxuan Wang

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, China

    23 shared publications
  • Xin Huang

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China; Department of Periodontology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China

    18 shared publications
  • Heyu Liu

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, China

    14 shared publications
  • Huiyi Wang

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, China

    14 shared publications
  • Chengzhang Li

    Department of Periodontology, School and Hospital of Stomatology, Wuhan University, Wuhan, Hubei, China

    13 shared publications

Latest Publications

  • The Slc2a3-VitC-TET2 positive feedback loop controls P. gingivalis-influenced cementogenesis: a key mechanism involving DNA methylation

    by Heyu Liu, Yifei Guo, Huiyi Wang, Jiahui Sun, Zhengkun Yang, Yuqi Liu, Zhendong Huang, Jiayi Ding, Jing Wu, Xiaoxuan Wang, et al.

    Background Cementum, a vital mineralized tissue for periodontal integrity, undergoes significant destruction during periodontitis. Porphyromonas gingivalis (P. gingivalis) is a key pathogen driving this cemental resorption; however, the specific mechanisms by which it epigenetically modulates cementoblast function through DNA methylation remain unclear. Methods This study employed an integrated multi-omics approach, combining Reduced Representation Bisulfite Sequencing (RRBS) and oxidative RRBS (oxRRBS), and high-throughput RNA sequencing, to profile the alterations in the DNA methylome of cementoblasts under mineralization conditions upon P. gingivalis infection. In vitro cementoblast cell line models and in vivo mouse models validated the specific mechanism. Results P. gingivalis modulated DNA methylation status during cementoblast mineralization and induced promoter hypermethylation of the Slc2a3 gene, thus repressing the expression of its encoded vitamin C (VitC) transporter, GLUT3. This suppression limited cellular VitC uptake, thereby directly impairing mineralization capacity and additionally suppressing it through the downregulation of the DNA demethylase TET2. Furthermore, we found that P. gingivalis modulated Slc2a3 methylation in part by targeting TET2. Conclusion P. gingivalis disrupted cementum homeostasis by perturbing a DNA methylation-based Slc2a3-VitC-TET2 positive-feedback loop, which is normally critical for cementogenesis. Consequently, TET2 and VitC represented attractive therapeutic targets with significant potential for reducing cementum resorption.

  • Open Access

    Epitranscriptomic landscapes in periodontitis: unraveling the regulatory roles of RNA Modifications

    by Yifei Guo, Heyu Liu, Li Ma, Xin Huang, Zhengguo Cao

    Epitranscriptomics has emerged as a rapidly expanding field investigating chemical modifications of RNA molecules that regulate gene expression without altering nucleotide sequences. Among these modifications, N6-methyladenosine (m6A) represents the most prevalent internal modification in eukaryotic messenger RNAs, with its dynamic and reversible regulation mediated by writers, erasers, and readers. Periodontitis, a chronic inflammatory disease affecting tooth-supporting tissues, involves complex interactions between microbial factors and host immune responses. Recent evidence has revealed significant roles for RNA modifications in periodontal pathogenesis, offering a molecular perspective on the disease heterogeneity influenced by host and environmental factors. This review synthesizes current understanding of how m6A and other RNA modifications contribute to periodontitis, examining their effects on key cellular processes including osteogenic differentiation, inflammatory responses, and bone remodeling. The involvement of specific modifications - including N4-acetylcytidine (ac4C), N6,2’-O-dimethyladenosine (m6Am), N7-methylguanosine (m7G), 5-methylcytosine (m5C), and N1-methyladenosine (m1A) - is also discussed. Furthermore, translational opportunities are explored, encompassing small molecule inhibitors targeting modification enzymes, repurposed pharmaceutical agents, natural compounds, and advanced biomaterials. The review highlights how epitranscriptomic mechanisms offer new perspectives on periodontal disease pathogenesis and presents emerging directions for diagnostic biomarker development and targeted therapeutic strategies.

  • Regulatory Effects of Bone Morphogenetic Protein‐4 on Tumour Necrosis Factor‐Alpha‐Induced IL‐6 and M‐CSF Expression in Cementoblasts

    by Yunlong Wang, Zhengguo Cao, Hong He, Zhijian Liu

    Objective: Orthodontically induced root resorption involves the destruction of cementum, and in severe cases, dentine. Cementoblasts are cells responsible for depositing and mineralizing cementum, and they can also communicate with osteoclasts to indirectly regulate cementum destruction. This study aimed to elucidate the impact of TNF‐α on IL‐6 and M‐CSF, two potent osteoclast‐activating cytokines secreted by cementoblasts. Additionally, the study explored the combined effects of BMP‐2, BMP‐4, BMP‐6, BMP‐7 and TNF‐α. Materials and Methods: We utilized the immortalized mouse cementoblast cell line OCCM‐30. Cells were incubated with TNF‐α, followed by RT‐qPCR and ELISA to assess IL‐6 and M‐CSF expression. Prior to TNF‐α stimulation, cells were pre‐incubated with inhibitors targeting p38 MAPK, Erk1/2, JNK, PI3K‐Akt, or NF‐κB pathways, and IL‐6 and M‐CSF levels were analysed by RT‐qPCR. Cells were also treated with combinations of BMP‐2, BMP‐4, BMP‐6, BMP‐7 and TNF‐α, and their synergistic effects on IL‐6 and M‐CSF were evaluated by RT‐qPCR and ELISA. Results: TNF‐α significantly increased both IL‐6 and M‐CSF mRNA levels, as well as their secreted levels. Blocking the NF‐κB pathway partially reversed TNF‐α‐induced upregulation of IL‐6 and M‐CSF. BMP‐4 and BMP‐2 further potentiated TNF‐α‐induced upregulation of IL‐6 and M‐CSF, while BMP‐6 and BMP‐7 had no effect. Conclusion: TNF‐α increased IL‐6 and M‐CSF expression in cementoblasts via the NF‐κB pathway. BMP‐4 and BMP‐2 exacerbated the TNF‐α‐induced effect on IL‐6 and M‐CSF.

  • Open Access

    Harnessing Natural Extracellular Vesicles to Combat Age-Related Diseases: From Aging Drivers to Therapeutic Opportunities

    by Shijie Lv, Jirong Xie, Xin Huang, Zongshuai Liu, Junjie Shi, Zhengguo Cao, Zhengjun Shang

    Aging is a complex biological process that leads to a growing burden of age-related diseases (ARD). Cellular senescence, which involves irreversible cell cycle arrest and the release of senescence-associated secretory phenotype (SASP), plays a central role in aging and the development of ARD. Natural extracellular vesicles (NEVs) refer to vesicles that derived from cells, organs and body fluids without artificial interventions. In recent years, NEVs have gained attention as mediators of intercellular communication, and showed multifunctional potential in regulating cellular senescence and ARD. On the one hand, these vesicles are capable of spreading senescence signals by transferring molecules such as miRNAs, proteins, and DNA fragments. On the other hand, NEVs derived from animal cells, body fluids, plant cells, and bacteria have demonstrated potential anti‑aging effects. This review synthesizes research findings from the past two decades, with a particular focus on studies published in the last five years that elucidate the molecular mechanisms by which NEVs regulate cellular senescence. This review aims to summarize various applications (biomarkers, drug delivery vehicles, direct therapeutic agents) of NEVs in major ARD, including neoplasms, cardiovascular diseases, neurodegenerative disorders, bone diseases, and diabetes. Several challenges including standardizing production, targeted delivery, mechanism exploration, and clinical translation are also discussed. Combining bioengineering, multi-omics technologies, and improved model systems could be important to fully utilize the potential of NEVs, and offer precise, safe, and effective strategies for ARD therapy.

  • Open Access

    Targeting CKIP ‐1 for Disease Therapy: Cellular Functions, Molecular Networks, and Clinical Potential

    by Xin Huang, Shijie Lv, Lejia Li, Jirong Xie, Zhengguo Cao

  • Association of dietary patterns with the prevalence of rheumatic diseases among older Chinese adults: a national cross-sectional survey

    by Ting Cen, Zhendong Huang, Junbo Xiang, Zhengguo Cao

    Objectives Rheumatic diseases are prevalent chronic conditions among older adults. This study investigates the associations between four dietary patterns, including anti-inflammatory diet (AID), protein-enriched diet (PED), Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, and plant-based diet (PBD), and the prevalence of rheumatic diseases in older Chinese populations. Method Data for this study were derived from the 2018 wave of the Chinese Longitudinal Healthy Longevity Survey. Logistic regression was employed to analyze the associations between AID, PED, MIND, PBD, and the prevalence of rheumatic diseases. Additionally, the study employed a series of analytical techniques, including Restricted Cubic Spline (RCS) analysis and subgroup analysis to ensure the robustness of our findings. Results A total of 5240 participants were included in this cross-sectional survey analysis. After controlling all covariates included, per one-score increase in the AID was associated with a 13.7% lower prevalence of rheumatic diseases (OR = 0.863, 95% CI: 0.775–0.959, P = 0.007), and per one-score increase in the MIND was associated with a 12.4% lower prevalence (OR = 0.876, 95% CI: 0.813–0.943, P < 0.001). RCS analysis showed a linear relationship between AID, MIND, and the prevalence of rheumatic diseases. Furthermore, both AID and MIND were associated with a lower prevalence of rheumatic diseases in individuals with low muscle mass. Conclusions Higher adherence to AID and MIND diets, and the maintenance of normal muscle mass, were associated with a lower prevalence of general self-reported rheumatic diseases in older adults. However, their associations with specific rheumatic subtypes remain to be further explored. Key Points • Among older Chinese adults, AID and MIND diets are associated with a lower prevalence of general self-reported rheumatic diseases. • Specific food groups within the AID and MIND, such as fresh fruits and legumes, are associated with a lower prevalence of general self-reported rheumatic diseases. • Adherence to AID and MIND diets is associated with lower general self-reported rheumatic disease prevalence in individuals with low muscle mass.

  • Open Access

    Author Correction: KDM6B/Pdk1 glycolytic pathway-driven ZEB2 lactylation promotes cellular cementum formation

    by Zhengkun Yang, Huiyi Wang, Junhong Xiao, Qiudong Yang, Jiahui Sun, Heyu Liu, Zhendong Huang, Li Ma, Xin Huang, Chuan Wang, et al.

  • Tryptophan-enriched Lactobacillus rhamnosus GG-derived Nanovesicles Promote Alveolar Bone Regeneration Through Macrophage Fatty Acid Oxidation

    by Zhendong Huang, Yuqi Liu, Qiudong Yang, Jiayi Ding, Zhengkun Yang, Heyu Liu, Xin Huang, Xiaoxuan Wang, Li Ma, Zhengguo Cao

    Inflammatory bone loss represents a major clinical challenge, leading to irreversible tissue damage and impaired function. Probiotic-derived nanovesicles show immense potential as novel cell-free nanomedicines; however, the lack of clarity regarding their precise mechanism of action in bone tissue regeneration restricts their clinical application. This study utilized a ligature-induced periodontitis mouse model (in vivo) and in vitro models, including macrophage functional assays and macrophage–osteoblast co-culture systems, to investigate the therapeutic effects and mechanism of Lactobacillus rhamnosus GG-derived extracellular vesicles (LEVs). In the periodontitis mouse model, LEVs effectively mitigated inflammatory infiltration and promoted alveolar bone regeneration. In vitro studies demonstrated that LEVs enhance macrophage polarization toward a reparative (M2) phenotype. Mechanistically, we identify LEVs as bioactive nanocarriers that deliver tryptophan metabolites. Upon internalization by macrophages, these metabolites trigger a critical metabolic and phenotypic shift by activating the aryl hydrocarbon receptor (AhR). Further research revealed that this effect is mediated by the AhR/NAD(P)H:quinone oxidoreductase 1 (NQO1)/carnitine palmitoyltransferase 1A (CPT1A) signaling axis: AhR transcriptionally up-regulates NQO1, which critically inhibits the 26S proteasome-mediated degradation of CPT1A. The resulting sustained CPT1A expression dramatically boosts fatty acid oxidation, which is essential for driving the reparative macrophage phenotype. These findings highlight the critical role and molecular delivery mechanisms of probiotic-derived nanovesicles in ameliorating inflammatory bone loss via immunometabolic reprogramming, thereby providing new targets and a theoretical basis for their application as nanocarriers in regenerative biomaterials.

  • Open Access

    ANGPTL2 inhibits macrophage pyroptosis and alleviates rheumatoid arthritis progression by regulating mitophagy via IGFBP5

    by Yuqi Liu, Qiudong Yang, Zhendong Huang, Jiahui Sun, Junhong Xiao, Zhengkun Yang, Xin Huang, Li Ma, Xiaoxuan Wang, Chuan Wang, et al.

    Dysregulated macrophage pyroptosis and impaired mitophagy have emerged as critical drivers of rheumatoid arthritis (RA) progression, yet their upstream regulatory mechanisms remain unclear. Previous studies have demonstrated that ANGPTL2 deficiency aggravates alveolar bone loss in periodontitis, a condition that shares mechanistic similarities with RA in terms of bone destruction. Given the established link between periodontitis and RA, these findings suggest that ANGPTL2 may also play a protective role in RA-related joint pathology. In this study, we demonstrate that ANGPTL2 deficiency worsens joint inflammation, bone erosion, and macrophage pyroptosis in mice with collagen-induced arthritis (CIA). Mechanistically, ANGPTL2 loss impairs mitophagy and promotes mitochondrial dysfunction by inhibiting IGFBP5, leading to sustained NLRP3 inflammasome activation. Intra-articular administration of AAV- Angptl2 restores mitophagy, suppresses pyroptosis, and alleviates RA pathology. These findings identify ANGPTL2 as a key regulator of macrophage mitophagy and suggest its therapeutic potential in RA.